-
Intellia Therapeutics, Inc. is an
American clinical-stage
biotechnology company focused on
developing novel,
potentially curative therapeutics leveraging...
- of
Intellia Therapeutics". www.businesswire.com.
November 18, 2014.
Archived from the
original on May 16, 2021.
Retrieved May 16, 2021. "
Intellia Therapeutics...
-
Indian Drugs and
Pharmaceuticals (1961– )
Intarcia (1995– )
Intas (1984– )
Intellia Therapeutics (2014– )
Ionis (1989– ) Ipca (1949– )
Ipsen (1929– ) ITH (2008–...
-
Healthcare products Regulatory Agency as of
April 2023[update].
Editas Medicine Intellia Therapeutics "CRISPR
Therapeutics AG 20243
Annual Report". U.S. Securities...
-
develop therapies for rare
diseases using CRISPR.
CRISPR Therapeutics Intellia Therapeutics Editas Medicine "Beam
Therapeutics Inc. FORM 10-K". U.S. Securities...
- TreeCo; and Co-Founder and
member of the
Scientific Advisory Board of
Intellia Therapeutics. His
research focuses on CRISPR-Cas9 in bacteria. In 2017...
- 2019, the five
directors were John Leonard,
chief executive officer of
Intellia Therapeutics;
Jeffrey Smith, Starboard's own
chief executive officer; Janet...
- "Declaration - Garage.pdf" (PDF).{{cite web}}: CS1 maint: url-status (link) "
Intellia". "Active
Business Park - activeacres". 12 May 2023. "Ecostation". "Ecospace...
- XPND Capital, a
private equity firm. In 1993, at age 21,
Tallifer founded Intellia, an e-commerce
service provider later bought by Quebecor. He
worked at...
-
Amgen Bayer Bristol Myers Squibb Editas Medicine Eli
Lilly and
Company Intellia Therapeutics Ipsen Ironwood Pharmaceuticals Merck & Co.
Novartis Novo Nordisk...
